Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
By
MedTech Outlook | Friday, March 01, 2024
Distribution Agreement Brings LungVision™ AI-Powered Image Guidance to South Korea
CAMPBELL, Calif.,-- Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today it has signed an exclusive distribution agreement with DK Healthcare Co., Ltd. to expand access of its cutting-edge LungVision™ real-time, intraoperative CT imaging system to South Korea.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
LungVision™ uses artificial intelligence (AI) to transform any C-arm fluoroscope into a cone-beam CT (CBCT) imaging system with advanced navigation capabilities. LungVision™'s real-time imaging gives bronchoscopists the confidence to biopsy from small pulmonary lesions with greater speed and precision, maximizing the likelihood for earlier-stage cancer detection and improved lung cancer survival.
"South Korea has one of the world's most aggressive lung cancer detection and diagnosis programs," said David Webster, CEO of Body Vision Medical. "This agreement with DK Healthcare not only provides Korean clinicians and patients access to the latest in lung cancer diagnostics technology, but with LungVision™ in their armamentarium, provides the Korean healthcare system a clinically- and cost-effective means to diagnose lung cancer patients at scale."
Body Vision Medical aims to expand lung patient access to LungVision™ into 60 markets by 2025 and, with this most recent distributorship signing, have a distribution footprint in 38 countries around the world.
More in News
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
